Cargando…
Characterization of a Brain Permeant Fluorescent Molecule and Visualization of Aβ Parenchymal Plaques, Using Real-Time Multiphoton Imaging in Transgenic Mice
[Image: see text] Emerging paradigms mandate discovery of imaging agents for diagnosing Alzheimer’s disease (AD) prior to appearance of clinical symptoms. To accomplish this objective, a novel heterocyclic molecule (4) was synthesized and validated as Aβ targeted probe. The agent shows labeling of n...
Autores principales: | Sundaram, G.S.M., Garai, Kanchan, Rath, Nigam P., Yan, Ping, Cirrito, John R., Cairns, Nigel J., Lee, Jin-Moo, Sharma, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372081/ https://www.ncbi.nlm.nih.gov/pubmed/25003699 http://dx.doi.org/10.1021/ol501264q |
Ejemplares similares
-
Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer’s Disease
por: Sundaram, G. S. M., et al.
Publicado: (2016) -
Reflection coefficients of permeant molecules in human red cell suspensions
Publicado: (1975) -
BENA435, a new cell-permeant photoactivated green fluorescent DNA probe
por: Erve, Alexandra, et al.
Publicado: (2006) -
Modulation of CFTR gating by permeant ions
por: Yeh, Han-I, et al.
Publicado: (2015) -
Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate
por: Li, Wan Hua, et al.
Publicado: (2021)